Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Tocira 400 Infusion

Prescription Icon
Prescription Required

Marketer

Hetero Healthcare Limited

Salt Composition

Tocilizumab (400mg)

Overview Tocira 400 Infusion

Infliximab 400mg intravenous infusion treats diverse inflammatory disorders affecting joints (rheumatoid, psoriatic, and ankylosing spondylitis), skin (psoriasis), and intestines (ulcerative colitis, Crohn's disease). Its mechanism involves TNF-alpha inhibition, reducing inflammation. Administration is exclusively by a healthcare provider; self-injection is prohibited. Consistent daily dosing maximizes efficacy. Continue treatment as directed, completing the prescribed course even with symptom improvement. Commonly reported adverse effects include headache, hypertension, upper respiratory infections, elevated liver enzymes, and nasopharyngitis. Persistent or troublesome side effects necessitate medical consultation; management strategies may be available. Increased infection susceptibility is possible. Report any infection signs (fever, cough, rash, diarrhea, influenza-like symptoms) immediately. Prior to treatment, inform your physician of any cardiac, renal, or hepatic issues, and list all concurrent medications. Regular blood tests may monitor blood cell counts throughout treatment. Pregnant or breastfeeding individuals should consult their doctor before initiating treatment.

Primary Ingredients of Tocira 400 Infusion

No information provided. Please provide the text you wish me to rephrase.

Uses of Tocira 400 Infusion

Managing ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease.

Major Benefits of Tocira 400 Infusion:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Tocira 400 Infusion:

  • Headache
  • High blood pressure
  • Upper respiratory tract infection
  • Injection site reactions (pain, swelling, redness)

How to use Tocira 400 Infusion:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Tocira 400 Infusion works:

Tocilizumab 400mg infusion inhibits inflammatory mediators, thereby mitigating the swelling, redness, and inflammation characteristic of specific arthritic conditions.

SAFETY ADVICE

AlcoholAlcoholSAFE

Tocira 400 Infusion may be consumed concurrently with alcohol without adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tocira 400 Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The administration of Tocira 400 Infusion while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Tocira 400 Infusion can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Tocira 400 Infusion requires careful administration in individuals with impaired renal function. Dosage modification of Tocira 400 Infusion may be necessary. Physician consultation is advised. Data regarding Tocira 400 Infusion use in patients exhibiting moderate to severe kidney impairment is limited. No dosage changes are indicated for patients with mild kidney disease.

LiverLiverCAUTION

Tocira 400 Infusion requires careful administration in individuals with hepatic impairment. Dosage modification for Tocira 400 Infusion might be necessary. Physician consultation is advised. Tocira 400 Infusion is contraindicated in patients exhibiting active liver disease.

What if you forget to take Tocira 400 Infusion :

Should you forget a Tocira 400 Infusion dose, seek your physician's advice.

Facts to Know About Tocira 400 Infusion

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Medications
Behavior Class Biologic Disease-Modifying Antirheumatic Drugs (bDMARDs)

FAQs on Tocira 400 Infusion

Tocilizumab 400 mg infusion is indicated for treating moderate to severe COVID-19 patients with persistent, worsening hypoxia despite 24–48 hours of corticosteroids and supportive care.
Tocilizumab 400 mg infusion isn't suitable for all COVID-19 patients due to potential risks. It may worsen infection and viral shedding, necessitating careful consideration of benefits versus risks before administration.
Tocira 400 Infusion may cause serious side effects, including anaphylaxis during infusion, elevated liver enzymes (transaminitis), low white blood cell counts (leukopenia and neutropenia, increasing infection risk), and serious bacterial, viral, or reactivated tuberculosis infections.
Tocira 400 Infusion is contraindicated in patients with abnormal liver enzyme levels (transaminitis), low platelet counts (<50,000), active tuberculosis, or any active bacterial or viral infection. It should also not be used during pregnancy or breastfeeding due to the risk of serious complications.
If your condition doesn't improve after Tocira 400 Infusion, your doctor will determine the next steps. Tocira 400 Infusion reduces lung inflammation, but doesn't repair pre-existing damage; lung recovery takes time. Continued shortness of breath warrants further investigation for other lung (e.g., pulmonary intravascular coagulopathy) or heart (cardiac dysfunction) problems. Any concurrent bacterial infections will require additional treatment.
Tocira 400 Infusion
43,659